Evidence map›Paper›PMID 39562574›Full record

ArticleNPJ science of food2024

Akkermansia muciniphila ONE effectively ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice.

Hongyan Zhang, Yue Pan, Ying Jiang, Mengling Chen, Xin Ma, Xueping Yu, Dayong Ren, Bin Jiang

Abstract read
In one paragraph

Article in NPJ science of food, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Strain-dependent efficacy of pasteurizedFrontiers in nutrition · 2026
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hongyan ZhangCollege of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin Province, China.
Yue PanCollege of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin Province, China.
Ying JiangCollege of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin Province, China.
Mengling ChenCollege of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin Province, China.
Xin MaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Xueping YuState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Dayong RenCollege of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin Province, China. rdy79@163.com.ORCID http://orcid.org/0000-0002-4300-4728
Bin JiangCollege of Food Science and Engineering, Jilin Agricultural University, Changchun, Jilin Province, China. binj@jlau.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Akermansia muciniphila shows promise as a next-generation probiotic, however, its beneficial regulatory effects on mice ulcerative colitis (UC) has not been extensively investigated. We used an Akkermansia muciniphila strain (AKK ONE) isolated from healthy human feces to study its effect on DSS-induced colitis in mice. Our results demonstrate that AKK ONE supplementation significantly improves food intake, weight, colon length, disease activity index (DAI) score, organ index, and tissue damage of colitis mice. AKK ONE notably improved intestinal barrier integrity by significantly enhancing expression of occludin and claudin-1. Additionally, AKK ONE reduced inflammation by down-regulating IL-1β, IL-6, and TNF-α, and up-regulating IL-10. In addition to reducing excessive inflammation, AKK ONE also increased the abundance of Akkermansia and decreased the abundance of Bacteroides. Furthermore, the AKK ONE intervention markedly increased SCFAs in cecal contents. AKK ONE may be a potential therapeutic agent for improving UC, based on the findings of this study.

Identifiers

PMID39562574
PMCPMC11576909

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.